Keeping Your Nose in Front
With the right partner to help you harness the many benefits, nasal delivery is not to be sniffed at
Charles Evans | | Opinion
Pharmaceutical developers are waking up to the idea that drug delivery via the nose could offer advantages for their target product, patient population, and indication. Traditionally, many formulators tend to think of oral dosing first – their comfort zone – followed by an injectable, if the oral route is not suitable. Other routes of delivery, such as nasal sprays, were typically only considered when all else failed.
Thanks to an increased focus on patient needs over recent years, nasal delivery is now moving to the forefront of formulators’ psyches – notably, at the very start of the development process. Development teams are establishing target product profiles early on and recognizing the benefits of establishing the needs of prescribers and patients from the outset.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine